Abstract
In 1919, Ernest Goodpasture described the case of a young man with a fatal illness characterized by hemoptysis, alveolar hemorrhage and necrosis, and proliferative glomerulonephritis (1). Stanton and Tange, in 1958, were the first to use the eponym Goodpasture’s syndrome to describe cases of pulmonary hemorrhage and necrotizing glomerulonephritis (2), although a large number of similar cases have been reported in the literature since the original description by Goodpasture. The original diagnosis of this syndrome was based on the clinical presence of pulmonary and renal involvement, and the underlying pathology described in literature reports varied. As we have come to understand, such pulmonary-renal syndromes have more than one etiology (Table 1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Goodpasture EW: The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci 158: 863, 1919.
Stanton MC, Tange JD: Goodpasture’s syndrome: pulmonary hemorrhage associated with glomerulonephritis. Australas Ann Med 7: 132, 1958.
Lindemann W: Sur la mode d’action de certains poisons renaux. Ann Inst Pasteur Immunol 14: 49, 1900.
Ortega LG, Mellors RC: Analytical pathology IV. The role of localized antibodies in the pathogenesis of nephrotic nephritis in the rat. J Exp Med 104: 151, 1956.
Scheer RL, Grossman MA: Immune aspects of the glomerulonephritis associated with pulmonary hemorrhage. Ann Intern Med 60: 1009, 1964.
Lerner RA, Glssock RJ, Dixon FJ: The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 126: 989, 1967.
Davison AM: Seasonal incidence of glomerulonephritis: findings of the UK Medical Research Council’s Glomerulonephritis Registry. Abstracts of IX International Congress of Nephrology, Los Angeles, 1984.
Segelmark M, Butkowski R, Wieslander J: Antigen restriction and IgG subclasses among anti-GBM autoantibodies. Nephrol Dial Transplant 5: 991, 1990.
Savage COS, Noel LH, Pusey CD, et al.: Antiglomerular basement membrane antibody mediated disease in the British Isles 1980–4. Br Med J (Clin Res) 292: 301, 1986.
Wilson CB: Nephritogenic immune responses involving basement membrane and other antigens in or of the glomerulus. In: NB Cummings, AF Michael, CB Wilson, eds, Immune Mechanisms in Renal Disease. Plenum, New York, p 233, 1983.
Benoit FL, Rulon CB, Theil GB, et al.: Goodpasture’s syndrome. A clinicopathologic entity. Am J Med 37: 424, 1964.
Proskey AJ, Weatherbee L, Easterling RE, et al.: Good-pasture’s syndrome. A report of five cases and review of the literature. Am J Med 48: 162, 1970.
Turner N, Lockwood CM, Rees AJ: Antiglomerular basement membrane antibody-mediated nephritis. In: RW Schrier, CW Gottschalk, eds, Diseases of the Kidney, 5th ed. Little, Brown, Boston, p 1865, 1992.
Perez GO, Bjornsonn S, Ross ALI, et al.: A mini epidemic of Goodpasture’s syndrome. Nephron 13: 161, 1974.
Simpson IJ, Doak PB, Williams LC, et al.: Plasma exchange in Goodpasture’s syndrome. Am J Nephrol 2: 301, 1982.
Williams PS, Davenport A, McDicken I, et al.: Increased incidence of anti-glomerular basement membrane antibody (anti-GBM) nephritis in the Mersey region, September 1984-October 1985. Q J Med 68: 727, 1988.
Wilson CB, Smith RC: Goodpasture’s syndrome associated with influenza A2 virus infection. Ann Intern Med 76: 91, 1972.
Wilson CB, Dixon FJ, Evans AS, et al.: Antiviral antibody responses in patients with renal diseases. Clin Immunol Immunopathol 2: 121, 1973.
Beirne GJ, Wagnild JP, Zimmerman SW, et al.: Idiopathic crescentic glomerulonephritis. Medicine 56: 349, 1977.
Wilson CB, Dixon FJ: The renal response to immunologic injury. In: BM Brenner, FC Rector, eds, The Kidney, 3rd ed. Saunders, Philadelphia, p 800, 1986.
Donaghy M, Rees AJ: Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 2: 1390, 1983.
Beirne GJ, Brennan JT: Glomerulonephritis associated with hydrocarbon solvents. Arch Environ Health 25: 365, 1972.
Daniell WE, Couser WG, Rosenstock L: Occupational solvent exposure and glomerulonephritis: a case report and review of the literature. JAMA 259: 2280, 1988.
Nelson NA, Robins TG, Port FK: Solvent nephrotoxicity in humans and experimental animals Am J Nephrol 10: 10, 1990.
D’Apice AJF, Kincaid-Smith P, Becker GJ, et al.: Good-pasture’s syndrome in identical twins. Ann Intern Med 88: 61, 1978.
Simonsen H, Brun C, Frokjaer-Thomsen O, et al.: Good-pasture’s syndrome in twins. Acta Med Scand 212: 425, 1982.
Almkuist RD, Buckalew VM, Hirszel P, et al.: Recurrence of anti-glomerular basement membrane antibody mediated glomerulonephritis in an isograft. Clin Immunol Immunopathol 18: 54, 1981.
Burns A, Li P, So A, et al.: HLA class II restrictions in Goodpasture’s syndrome. Nephrol Dial Transplant 5: 297, 1990.
Dunckley H, Chapman JR, Burke J, et al.: HLA-DR and -DQ genotyping in anti-GBM disease. Dis Markers 9: 249, 1992.
Rees AJ, Demaine AG, Welsh KI: Association of immunoglobulin Gm allotypes with antiglomerular basement membrane antibodies and their titre. Hum Immunol 10: 213, 1984.
Relman AS, Dvorak HF, Colvin RB: Case records of the Massachusetts General Hospital: weekly clinicopathological exercises. Case 46–1971. N Engl J Med 285: 1187, 1971.
Wahls TL, Bonsib SM, Schuster VL: Coexistent Wegener’s granulomatosis and anti-glomerular basement membrane disease. Hum Pathol 18: 202, 1987.
Klassen J, Elwood C, Grossberg AL, et al.: Evolution of membranous nephropathy into anti-glomerular-basementmembrane glomerulonephritis. N Engl J Med 290: 1340, 1974.
Moorthy AV, Zimmerman SW, Burkholder PM, et al.: Association of crescentic glomerulonephritits with membranous glomerulonephropathy: a report of three cases. Clin Nephrol 6: 319, 1976.
Richman AI, Rifkin SI, McAllister CJ: Rapidly progressive glomerulonephritis. Combined anti-glomerular basement membrane antibody and immune complex pathogenesis. Hum Pathol 12: 597, 1981.
Weber MF, Andrassy K, Pullig O, et al.: Antineutrophilcytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture’s syndrome and Wegener’s granulomatosis. J Am Soc Nephrol 2: 1227, 1992.
Guerin V, Rabin C, Noel LH, et al.: Anti-glomerular basement membrane disease after lithotripsy. Lancet 1: 856, 1990.
Hudson BG, Kalluri R, Gunwar S, et al.: Molecular characteristics of the Goodpasture autoantigen. Kidney Int 43: 135, 1993.
Butkowski RJ, Langeveld JPM, Wieslander J, et al.: Localization of the Goodpasture epitope to a novel chain of basement membrane collagen. J Biol Chem 262: 7874, 1987.
Saus J, Wieslander J, Langeveld JPM, et al.: Identification of the Goodpasture antigen as the alpha 3 (IV) chain of collagen IV. J Biol Chem 263: 13374, 1988.
Hudson BG, Reeders ST, Tryggvason K: Type IV collagen: structure, gene organization, and role in human diseases. J Biol Chem 268: 26033, 1993.
Kalluri R, Gunwar S, Reeders ST, et al.: Goodpasture syndrome. Localization of the epitope for the autoantibodies to the carboxyl-terminal region of the alpha 3 (IV) chain of basement membrane collagen. J Biol Chem 266: 24018, 1991.
Wieslander J, Langeveld JPM, Butkowski R, et al.: Physical and immunochemical studies of the globular domain of type IV collagen. Cryptic properties of the Goodpasture antigen. J Biol Chem 260: 8564, 1985.
Barker DF, Hostikka SL, Zhou J, et al.: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248: 1224, 1990.
Kleppel MM, Kashtan C, Santi PA, et al.: Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis. Lab Invest 61: 278, 1989.
Savage COS, Noel LH, Crutcher E, et al.: Hereditary nephritis: immunoblotting studies of the glomerular basement membrane. Lab Invest 60: 613, 1989.
Hudson BG, Kalluri R, Gunwar S, et al.: The pathogenesis of the Alport syndrome involves type IV collagen molecules containing the alpha 3 (IV) chain: evidence from anti-GBM nephritis after renal transplantation. Kidney Int 42: 179, 1993.
Wilson CB: Nephritogenic antibody mechanisms involving antigens within the glomerulus. Immunol Rev 55: 257, 1981.
Wilson CB, Dixon FJ: Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 3: 74, 1973.
Jampol LM, Lahar M, Albert DM, et al.: Ocular clinical findings and basement membrane changes in Goodpasture’s syndrome. Am J Ophthalmol 79: 452, 1975.
Turner N, Rees AJ: Anti-glomerular basement membrane disease. In: SJ Cameron, AM Davison, JP Grunfeld, et al., eds, Oxford Textbook of Nephrology. Oxford University Press, Oxford, p 876, 1991.
Gallo GR: Elution studies in kidneys with linear deposition of immunoglobulin in glomeruli. Am J Pathol 61: 377, 1970.
Koffler D, Agnello V, Carr RI, et al.: Variable patterns of immunoglobulin and complement deposition in the kidneys of patients with systemic lupus erythematosus. Am J Pathol 56: 305, 1969.
Querin S, Noel LH, Grunfeld JP, et al.: Linear glomerular IgG fixation in renal allografts: incidence and significance in Alport’s syndrome. Clin Nephrol 25: 134, 1986.
Westberg NG, Michael AF: Immunohistopathology of diabetic glomerulonephritis. Diabetes 21: 163, 1972.
Wilson CB, Dixon FJ: Diagnosis of immunopathologic renal disease. Kidney Im 5: 389, 1974.
Nowakowski A, Grove RB, King LH, et al.: Goodpasture’s syndrome: recovery from severe pulmonary hemorrhage after bilateral nephrectomy. Ann Intern Med 75: 243, 1971.
Eisinger AJ: Goodpasture syndrome: failure of nephrectomy to cure pulmonary hemorrhage. Am J Med 55: 565, 1973.
Cohen LH, Wilson CB, Freeman RM: Goodpasture’s syndrome: recovery after severe renal insufficiency. Arch Intern Med 136: 835, 1976.
Briggs WA, Johnson JP, Teichman S, et al.: Anti-glomerular basement membrane antibody-mediated glomerulonephritis and Goodpasture’s syndrome. Medicine (Baltimore) 58: 348, 1979.
Wu MJ, Moorthy AV, Beirne GJ: Relapse in anti-glomerular basement membrane antibody mediated crescentic glomerulonephritis. Clin Nephrol 13: 97, 1980.
Lockwood CM, Rees AJ, Pearson TA, et al Immunosuppression and plasma-exchange in the treatment of Goodpasture’s syndrome. Lancet 1: 711, 1976.
Johnson JP, Moore J, Austin HA, et al.: Therapy of antiglomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore) 64: 219, 1985.
Bolton WK, Sturgill BC: Methylprednisolone therapy for acute crescentic rapidly progressive glomerulonephritis. Am J Nephrol 9: 368, 1989.
Walker RG, Scheinkestel C, Becker GJ, et al.: Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (antiGBM) nephritis/Goodpasture’s syndrome. Q J Med 54: 75, 1985.
Querin S, Schurch W, Beaulieu R: Ciclosporin in Good-pasture’s syndrome. Nephron 60: 355, 1992.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Charney, D.I., Border, W.A. (1998). Goodpasture’s Syndrome. In: Suki, W.N., Massry, S.G. (eds) Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6632-5_22
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6632-5_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-6634-9
Online ISBN: 978-1-4757-6632-5
eBook Packages: Springer Book Archive